Cargando…
Correction: Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462497/ https://www.ncbi.nlm.nih.gov/pubmed/37516694 http://dx.doi.org/10.1007/s00464-023-10336-y |
| _version_ | 1785098044746760192 |
|---|---|
| author | van der Wielen, Nicole Daams, Freek Rosati, Riccardo Parise, Paolo Weitz, Jürgen Reissfelder, Christoph del Val, Ismael Diez Loureiro, Carlos Parada-González, Purificación Pintos-Martínez, Elena Vallejo, Francisco Mateo Achirica, Carlos Medina Sánchez-Pernaute, Andrés Campos, Adriana Ruano Bonavina, Luigi Asti, Emanuele L. G. Poza, Alfredo Alonso Gilsanz, Carlos Nilsson, Magnus Lindblad, Mats Gisbertz, Suzanne S. van Berge Henegouwen, Mark I. Romario, Uberto Fumagalli De Pascale, Stefano Akhtar, Khurshid Cuesta, Miguel A. van der Peet, Donald L. Straatman, Jennifer |
| author_facet | van der Wielen, Nicole Daams, Freek Rosati, Riccardo Parise, Paolo Weitz, Jürgen Reissfelder, Christoph del Val, Ismael Diez Loureiro, Carlos Parada-González, Purificación Pintos-Martínez, Elena Vallejo, Francisco Mateo Achirica, Carlos Medina Sánchez-Pernaute, Andrés Campos, Adriana Ruano Bonavina, Luigi Asti, Emanuele L. G. Poza, Alfredo Alonso Gilsanz, Carlos Nilsson, Magnus Lindblad, Mats Gisbertz, Suzanne S. van Berge Henegouwen, Mark I. Romario, Uberto Fumagalli De Pascale, Stefano Akhtar, Khurshid Cuesta, Miguel A. van der Peet, Donald L. Straatman, Jennifer |
| author_sort | van der Wielen, Nicole |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10462497 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104624972023-08-30 Correction: Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial van der Wielen, Nicole Daams, Freek Rosati, Riccardo Parise, Paolo Weitz, Jürgen Reissfelder, Christoph del Val, Ismael Diez Loureiro, Carlos Parada-González, Purificación Pintos-Martínez, Elena Vallejo, Francisco Mateo Achirica, Carlos Medina Sánchez-Pernaute, Andrés Campos, Adriana Ruano Bonavina, Luigi Asti, Emanuele L. G. Poza, Alfredo Alonso Gilsanz, Carlos Nilsson, Magnus Lindblad, Mats Gisbertz, Suzanne S. van Berge Henegouwen, Mark I. Romario, Uberto Fumagalli De Pascale, Stefano Akhtar, Khurshid Cuesta, Miguel A. van der Peet, Donald L. Straatman, Jennifer Surg Endosc Correction Springer US 2023-07-29 2023 /pmc/articles/PMC10462497/ /pubmed/37516694 http://dx.doi.org/10.1007/s00464-023-10336-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction van der Wielen, Nicole Daams, Freek Rosati, Riccardo Parise, Paolo Weitz, Jürgen Reissfelder, Christoph del Val, Ismael Diez Loureiro, Carlos Parada-González, Purificación Pintos-Martínez, Elena Vallejo, Francisco Mateo Achirica, Carlos Medina Sánchez-Pernaute, Andrés Campos, Adriana Ruano Bonavina, Luigi Asti, Emanuele L. G. Poza, Alfredo Alonso Gilsanz, Carlos Nilsson, Magnus Lindblad, Mats Gisbertz, Suzanne S. van Berge Henegouwen, Mark I. Romario, Uberto Fumagalli De Pascale, Stefano Akhtar, Khurshid Cuesta, Miguel A. van der Peet, Donald L. Straatman, Jennifer Correction: Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial |
| title | Correction: Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial |
| title_full | Correction: Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial |
| title_fullStr | Correction: Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial |
| title_full_unstemmed | Correction: Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial |
| title_short | Correction: Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial |
| title_sort | correction: three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a european randomized clinical trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462497/ https://www.ncbi.nlm.nih.gov/pubmed/37516694 http://dx.doi.org/10.1007/s00464-023-10336-y |
| work_keys_str_mv | AT vanderwielennicole correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT daamsfreek correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT rosatiriccardo correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT parisepaolo correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT weitzjurgen correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT reissfelderchristoph correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT delvalismaeldiez correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT loureirocarlos correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT paradagonzalezpurificacion correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT pintosmartinezelena correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT vallejofranciscomateo correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT achiricacarlosmedina correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT sanchezpernauteandres correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT camposadrianaruano correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT bonavinaluigi correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT astiemanuelelg correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT pozaalfredoalonso correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT gilsanzcarlos correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT nilssonmagnus correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT lindbladmats correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT gisbertzsuzannes correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT vanbergehenegouwenmarki correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT romarioubertofumagalli correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT depascalestefano correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT akhtarkhurshid correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT cuestamiguela correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT vanderpeetdonaldl correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial AT straatmanjennifer correctionthreeyearsurvivalanddistributionoflymphnodemetastasesingastriccancerfollowingneoadjuvantchemotherapyresultsfromaeuropeanrandomizedclinicaltrial |